J.F. Chatal - Concepedia

Author

J.F. Chatal

Also Known As

Chatal, J.F., J -F Chatal, J F Chatal, J. -F. CHATAL, J. F. Chatal, J.-F Chatal, J.-F. Chatal, J.F Chatal, J.F. CHATAL, J.F. Chatal

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre Hospitalier René-Dubos Nantes Université Centre National de la Recherche Scientifique Université Grenoble Alpes

About

J.F. Chatal is an author at Inserm specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	1.5K
2	Health Sciences	11	11	475
3	Engineering	1	1	40
4	Biochemistry	1	1	15
5	Biomolecular Engineering	1	1	15

J.F. Chatal

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. J.-P. Mach, J.F. Chatal, J. Lumbroso, PubMed Oncologic ImagingImmunologyPathologyParticular MabImmunotherapy	1983	284
A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase I. Resche, J.F. Chatal, A Pecking, European Journal of Cancer Bone DiseaseMedicineSpinal OncologyDose-controlled StudyOncology	1997	253
Immunoscintigraphy of colon carcinoma. J.F. Chatal, J.C. Saccavini, P. Fumoleau, PubMed Immunocytochemical TechniqueImmunologyGastroenterologyPathologyImmunotherapy	1984	207
Nuclear medical imaging using β+γ coincidences from 44Sc radio-nuclide with liquid xenon as detection medium C. Grignon, Jacques Barbet, Manuel Bardiès, Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment Detection MediumNuclear PhysicsMedical ImagingRadiation DetectionMedicine	2006	98
Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres Manuel Bardiès, J.F. Chatal Physics in Medicine and Biology	1994	91
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. P Peltier, C. Curtet, J.F. Chatal, PubMed PathologyImmunotherapy111In-labeled Dtpa DimerOncologyRadiopharmaceutical Therapy	1993	87
Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. J M Le Doussal, A. Chetanneau, Anne Gruaz‐Guyon, PubMed Surgical OncologyImmunologyImmunotherapyHapten InjectionOncology	1993	84
High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer Éric Mirallié, J.-P. Vuillez, Stéphane Bardet, The Journal of Clinical Endocrinology & Metabolism	2005	83
A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma. M.-A. Mahé, P. Fumoleau, Michel Fabbro, PubMed Surgical OncologyCancer ManagementGynecologyPhase Ii StudySurgery	1999	59
Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial. J.-P. Vuillez, Françoise Kraeber‐Bodéré, D Moro, PubMed Proved Sclc RelapseCell TherapyImmunologyPathologyStem Cells Transplantation	1999	54

Page 1